Eksperimental'naia i klinicheskaia farmakologiia 2010-10-01

[Pharmacological correction of the cytogenetic effects of cisplatin].

O L Voronova, O V Neupokoeva, E P Fedorova, A E Prosenko, A A Churin

Index: Eksp. Klin. Farmakol. 73(10) , 37-9, (2010)

Full Text: HTML

Abstract

Beginning with the first hours of experiments, cisplatin evoked an increase of chromosomal aberrations in CBA/CaLac bone marrow cells. Significant increase of structural infringements of chromosomes due to chromatid breaks was revealed in metaphase plates of murine bone marrow preparations through 24 h after cisplatin intraperitoneal introduction. In late terms of research (90th day), the high level of aberrations of chromosomes was retained. The most pronounced correction of cisplatin mutagenicity was achieved using a preliminary course of thiophan introduction.


Related Compounds

Related Articles:

Synthesis and evaluation of glycopolymeric decorated gold nanoparticles functionalized with gold-triphenyl phosphine as anti-cancer agents.

2014-10-13

[Biomacromolecules 15(10) , 3802-10, (2014)]

Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).

2005-05-05

[J. Med. Chem. 48 , 3269-79, (2005)]

Interactions of multitargeted kinase inhibitors and nucleoside drugs: Achilles heel of combination therapy?

2015-01-01

[J. Chromatogr. A. 1421 , 154-61, (2015)]

Targeting the Proangiogenic VEGF-VEGFR Protein-Protein Interface with Drug-like Compounds by In Silico and In Vitro Screening

2011-01-01

[Chem. Biol. 18(12) , 1631-9, (2011)]

[Hepatoprotective effect of thiophane in rats with experimental carbon tetrachloride-induced hepatitis].

2011-01-01

[Eksp. Klin. Farmakol. 74(8) , 37-40, (2011)]

More Articles...